Background Surgical treatment options for patients with cirrhosis and portal hypertension are complicated. In this study, we evaluated the effectiveness of a new treatment strategy, splenic auto-transplantation and oesophageal transection anastomosis. We report results from clinical observations, splenic immune function and portal dynamics in 274 patients. Methods From 1979 to 2005, 274 cirrhosis patients with portal hypertension underwent the new treatment strategy, and were followed up to compare results with those patients who underwent traditional surgical treatment. From 1999 to 2002, a randomized controlled trial (RCT) was performed on 40 patients to compare their post-operative immune function. From 1994 to 2006, another RCT enrolled 28 patients to compare portal dynamics using three-dimensional dynamic contrast-enhanced magnetic resonance angiography (3D DEC MRA) investigation post operation. Results Among 274 patients (mean age 41.8 years), the emergency operative mortality (4.4%), selective operative mortality (2.2%), complication rate (17.9%), prevalence of hepatic encephalopathy (<1%), rate of portal hypertension gastritis (PHG) bleeding (9.1%), and morbidity of hepatic carcinoma (8%) were similar to those patients undergoing traditional operation; the spleen immunology function (Tuftsin, IgM) decreased in both groups 2 months post operation, but this decrease did not reach statistical significance. Through 3D DCE MRA, the cross sectional area and the velocity and volume of blood flow of the main portal vein decreased significantly after operation in both groups. The velocity and volume of blood flow in the auto-transplantation group was significantly lower than that in the control group. Conclusions Splenic auto-transplantation and esophageal transection anastomosis is a safe, effective, and reasonable treatment strategy for patients with portal hypertension with varicial bleeding. It not only can correct hypersplenism, but may also achieve complete hemostasis. Spleens auto-transplanted into the retroperitoneal space can preserve immune function and establish broad collateral circulation.
he treatment of choice for bleeding esophageal varices in liver cirrhosis patients with portal hypertension is still a controversial worldwide problem. Even in the era of liver transplantation, only 5%-10% of portal hypertension cases are suitable for liver transplantation. 1 Compared with sclerotherapy and shunt operation, nonshunting operation is the most popular operative procedure in Eastern countries. 2 Splenectomy is a part of this traditional operation. However, from the modern viewpoint, spleen and splenic function should be preserved as best as possible. 3 In the past 26 years, 274 liver cirrhosis patients complicated with portal hypertension were treated surgically with splenic auto-transplantation and oesophageal transection anastomosis in our hospital. From a series of clinical and laboratory studies, we evaluate the effectiveness of this new treatment strategy from three perspectives: clinical index, splenic immune function, and portal dynamics.
METHODS

Patients
From 1979 to 2005, 274 patients with liver cirrhosis complicated with portal hypertension (splenomegaly, hypersplenism and bleeding of esophagogastric varices) underwent surgical treatment at the Department of General Surgery, Second Affiliated Hospital, Sun Yat-san University, Guangzhou, China. Among the 274 patients, 229 were male and 45 were female, aged 6-80 years, average 41.8 years. All patients had a history of bleeding from the upper digestive tract. Child-Pugh classification of liver function 4 showed grade A in 69 (25.2%) patients, grade B in 121 (44.2%), and grade C in 84 (30.6%).
Operative technique
All operations were performed after obtaining patients' written informed consent, and except for some emergencies, most were elective operations. Briefly, a single left subcostal laparotomy was chosen. After exposure of the surrounding splenic ligaments; all short gastric vessels were ligated except the branch that was close to the splenic pedicle. Following the ligation of the splenic vessels, subtotal splenectomy was performed and a fragment (5 cm×3 cm×1 cm) of the spleen was preserved near the splenic pedicle. Then the posterior peritoneum just above the left kidney was cut open, and a pocket in the retroperitoneal space was prepared by blunt dissection of the surrounding tissues to accommodate the splenic fragment, which had been marked with silver clips on its surface. After the splenic fragment was adjusted at its appropriate site, a few stitches were added close to the posterior peritoneal incision. Finally, the lowest thoracic part of the esophagus was progressively freed from the abdomen, and it was generally possible to free 8 to 10 cm of esophagus. Gastroesophageal devascularization was performed, followed by transection and anastomosis of the lower esophagus with a 25-29 mm stapler.
Design of study
Prospective clinical observation study From 1979 to 2005, 274 patients with liver cirrhosis complicated with portal hypertension received the above treatment. After operation and discharge, the patients were followed up for operative mortality, relapse of hypersplenism, incidence rate of recurrent bleeding, hepatic encephalopathy, hemorrhage of portal hypertension gastritis, and incidence of primary liver carcinoma.
Randomized controlled study
From July 1999 to August 2002, 40 patients (37 males and 3 females, average 46.8 years; liver function Child-Pugh A 26 cases, B 14 cases) with liver cirrhosis complicated with portal hypertension were randomly allocated into 2 groups by a surgical nurse, using a random number table: splenic auto-transplantation group (n=20), in which patients underwent splenectomy with retroperitoneal splenic auto-transplantation and esophageal transection anastomosis; control group (n=20), in which only splenectomy and esophageal transection were performed. The clinical observation index included: spleen immune function (Tuftsin, IgM), liver function (alanine aminotransferase (ALT), albumin (ALB), total bilirubin (TBL), aspartate aminotransferase (AST)), clinical outcome (blood loss during operation, operative mortality, incidence of recurrent bleeding, blood routine, operative time, days in hospital), and dynamic scintigraphy of the transplanted splenic fragment engaging technetium 99m Tc-labeled heat-damaged erythrocytes ( 99m Tc-DRBC). Serum tuftsin was detected preoperatively and 2 months after operation by means of reverse-phase high-performance liquid chromatography, as described by Naim et al. 5 Serum IgM was measured (Beckman Array 360 chemistry Analyzer; Global Medical Instrumentation Inc, Clearwater, USA) preoperatively and 2 months after surgery. From week 2 to week 32 after surgery, dynamic scintigraphy of the transplanted splenic fragment engaging technetium 99m Tc-labeled heat-damaged erythrocytes was performed in all patients at 8-week intervals, using methods described by Nielsen and Hagan. 6, 7 Three-dimensional dynamic contrast enhanced MR angiography (3D DCE MRA) study From September 1994 to November 2004, 28 patients (26 males and 2 females, average age 51.5 years; liver function Child-Pugh A 8 cases, B 20 cases) with liver cirrhosis complicated by portal hypertension were randomly allocated into 2 groups by a research nurse, using a random number table: splenic auto-transplantation group (n=14), in which patients underwent splenectomy with retroperitoneal splenic auto-transplantation and gastroesophageal devascularization; and control group (n=14), in which only splenectomy and gastroesophageal devascularization were performed. Every patient underwent 3D DEC MRA (1.5 T Gyroscan Intera Master, Philips, Netherlands) to measure cross sectional area of the main portal vein, volume of blood flow, and velocity of blood flow 1 week before operation and 6 months after operation. In the splenic auto-transplantation group, we also observed the blood supply, presence of collateral circulation, and direction of blood flow of the transplanted spleen.
Statistical analysis
Data are presented as mean±standard deviation (SD). Continuous data within groups were compared by paired t tests. Continuous data between groups were compared by Student's t test. Categorical data were analyzed by Chi-square test. A P value less than 0.05 was considered statistically significant. All analyses were performed by SPSS version 8.0.
RESULTS
Prospective clinical observation study
From long time follow-up (8 months to 26 years), we found that the emergency operative mortality and selective operative mortality were 4.4% (12/274) and 2.2% (6/274) respectively. The incidence of postoperative complication was 17.9% (49/274) (postoperative complications included subphrenic abscess, acute respiratory distress syndrome (ARDS), and pulmonary infection). The morbidity from hepatic encephalopathy was 0.7% (2/274). The bleeding rate of portal hypertension gastritis (PHG) was 9.1% (25/274), and morbidity from hepatic carcinoma was 8.0% (22/274). There were no differences between this new treatment strategy and traditional operation. We did not detect any leakage or stenosis in esophageal anastomosis.
Randomized control study
The results of the randomized immunologic study are shown in Tables 1-4. There were no significant differences between the 2 groups before operation in patient characteristics (auto-transplantation group: male 18, female 2, mean age 49.2 years, liver function Child-Pugh A 14, B 6; control group: male 19, female 1, mean age 46.1 years, liver function Child-Pugh A 12, B 8). There were no significant differences at baseline in serum tuftsin level, IgM, and liver function (P>0.05). After the operation, there were no significant differences in tuftsin, IgM level in the splenic auto-transplantation group, while the control group showed a significant decrease in tuftsin and IgM at 2 months post operation. At the same time, the tuftsin and IgM levels in the auto-transplantation group were significantly higher than that in the control group after operation, which suggested that immune function in the control group had been compromised after the operation. After the operation, there were no differences between the 2 groups in liver function. From scintigraphy, positive scanning of the splenic fragment was found in the auto-transplantation group (Fig. 1 ). 
3D DCE MRA study
Results from 3D DCE MRA are shown in Table 5 . There were no significant differences in cross sectional area of the main portal vein (MPV) between the 2 groups before operation. The cross sectional area decreased significantly after operation in the 2 groups. Cross sectional area in the auto-transplantation group appeared to be less than in control group, however, this difference did not reach statistical significance (P>0.05). In Tables 6 and 7 , there were no significant differences in velocity and volume of blood flow in the main portal vein between the 2 groups before operation, but all these decreased significantly after operation. The velocity and volume of blood flow in the auto-transplantation group was significantly lower than that in the control group after operation (P<0.05). Figs. 2-4 show the survival, the blood supply of auto- Fig. 1 . Scintigraphic scan of an auto-transplanted splenic fragment 2 months after surgery using 99m Tc-labeled heat-damaged erythrocytes. transplanted spleens, and the establishment of the collateral circulation using MRA.
DISCUSSION
China is the most populated country in the world, and unfortunately, the prevalence of hepatitis in China is also Fig. 3 . The blood supply of auto-transplanted spleen (MRA photo). Green arrow points to the blood supply from gastroepiploic artery, red arrow points to the auto-transplanted spleen. Fig. 4 . The collateral circulation of auto-transplanted spleen (MRA photo). Blue arrow points to the venous around the transplanted spleen shunt with left kidney, and shunt with posterior peritoneum blood vessel, green arrow points to the circuitous left ovarian vein, red arrow points to the auto-transplanted spleen. very high. With an estimated 112 million chronic hepatitis B carriers in 2004, 8 the morbidity and mortality related to hepatitis, especially cirrhosis, are increasing. Bleeding oesophageal varices is one of the life-threatening complications of portal hypertension in liver cirrhosis patients. Treatment choices include sclerotherapy and surgical intervention, each of which has advantages and disadvantages. 9 Devascularization or Sugiura procedure has been recommended because of low mortality and complication rates, low encephalopathy and low rebleeding rates. 10, 11 In our studies, all patients underwent splenic transplantation and transabdominal oesophageal transection, transection of the esophagus, and simultaneous stapled anastomoses. Results of our prospective clinical study suggested the operation can achieve hemostasis, although the bleeding rate of portal hypertension gastritis is still as high as 9.1%, which is similar to previous reports. 12 Certain characteristics are responsible for the good hemostasis results. First, a very extensive devascularization is performed that achieves porto-azygos disconnection at the level of the esophagogastric area, which is the area where most variceal hemorrhages occur. Second, esophageal transection interrupts three layers of varices in the sub-mucosal tissues, which are normally not interrupted in other types of devascularization procedures. Additionally, only the porto-azygos connections through the esophagogastric are interrupted, and portal perfusion can be maintained. Furthermore, the devascularization procedures are relatively easy to learn for most surgeons because no special vascular surgical techniques are needed. Esophagus anastomosis with a stapler can shorten operative time, and no complication related to anastomosis, either leakage or stenosis, were detected in patients during the early postoperative period of follow-up.
Today, the concept of spleen function requires re-evaluation. The spleen is an important organ with a complex function. Overwhelming post-splenectomy infection (OPSI) is the "punishment" for splenectomy. Simply splenectomy in the Sugiura operation may induce a series of important alterations in the immune response. Auto-transplantation of splenic fragments after splenectomy has been advocated as a method of retaining normal splenic immune function in the treatment of splenic trauma or splenomegaly caused by hematologic disorders. [13] [14] [15] However, it is unclear whether preservation of splenic tissue with splenomegaly will be beneficial to patients with portal hypertension and cirrhosis. Tuftsin is considered as a sensitive marker to evaluate humoral immune function of the spleen. [16] [17] [18] In our study, the levels of serum tuftsin decreased markedly in the control group 2 months after surgery, whereas concentrations remained stable in the splenic auto-transplantation group. These results indicate that splenic auto-transplantation preserves tuftsin activity after splenectomy. The spleen is also the site of IgM production. Splenectomy leads to a reduction of IgM in peripheral blood. 19 In clinical trials, splenic auto-transplantation maintained normal IgM levels after splenectomy. 20, 21 Similarly, in our study, the levels of serum IgM significantly decreased in the splenectomy group after operation, whereas levels remained normal in the auto-transplantation group. Collectively, these data demonstrate that splenic auto-transplantation can helping maintaining normal humoral immune function. The optimal mass and site of the transplanted splenic fragment in patients with portal hypertension and cirrhosis remain unknown. On the basis of our results, it appears that a 15-cm 3 volume of transplanted splenic tissue can preserve tuftsin and IgM activity. We regard the posterior peritoneum to be the appropriate transplantation site because the operation process is relatively easy and safe. Also, dynamic scintigraphy of the transplanted splenic fragment engaging 99m Tc-labeled heat-damaged erythrocytes ( 99m Tc-DRBC) 2-8 months after operation showed that the auto-transplanted spleen survived well, and we found no relapse of hypersplenism after operation during follow-up lasting up to 26 years.
From 1979, we treated more than 200 portal hypertension patients with splenic auto-transplantation and oesophageal transection anastomosis, and although the clinical results have been encouraging, we sought to find a non-invasive and direct way to evaluate the curative effects of operation. 3D DCE MRA is the new and valuable imaging method that is readily utilized by surgeons and radiologists because of its big and direct field, easy and fast imaging, and ability to clearly demonstrate vessels. 22, 23 Using 3D DCE MRA, we found that the cross sectional area of the main portal vein, and the velocity and volume of blood flow of the main portal vein after operation were lower than before operation. These results compare favorably with those obtained after traditional devascularization operations. 24 Interestingly, in our studies, velocity and volume of blood flow of the main portal vein after operation in the splenic autotransplantation group was significant lower than that in the control group. This suggests that some factor decreases the pressure in the portal vein. From MRA imaging, we found the auto-transplanted spleen can establish extensive collateral circulation with posterior peritoneal blood vessels, and subsequently, the blood in the high pressure portal vein would shunt to the posterior peritoneal veins through the transplanted spleen, and thus decrease the portal pressure.
In conclusion, splenic auto-transplantation and oesophageal transection anastomosis is a safe, effective, and reasonable treatment strategy in patients with portal hypertension. This surgical strategy can not only correct hypersplenism, but may also achieve hemostasis, and the auto-transplanted spleen in the retroperitoneal space can preserve immune function and establish collateral circulation.
